The Technical Analyst
Shockwave Medical Inc [SWAV]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Shockwave Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
0.04% $328.99
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 12 336 mill |
| EPS: | 3.85 |
| P/E: | 85.45 |
| Earnings Date: | May 06, 2024 |
| SharesOutstanding: | 37.50 mill |
| Avg Daily Volume: | 1.071 mill |
| RATING 2024-04-25 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 85.45 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.38x |
| Company: PE 85.45 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-213.84 (-165.00%) $-542.83 |
| Date: 2024-04-26 |
| Expected Trading Range (DAY) |
|---|
|
$ 318.92 - 339.06 ( +/- 3.06%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-26 | Francis Laura | Sell | 1 500 | Stock Option |
| 2024-03-26 | Francis Laura | Buy | 1 500 | Common Stock |
| 2024-03-26 | Francis Laura | Sell | 1 500 | Common Stock |
| 2024-03-26 | Francis Laura | Buy | 1 500 | Common Stock |
| 2024-03-26 | Francis Laura | Sell | 1 500 | Common Stock |
| INSIDER POWER |
|---|
| -13.77 |
| Last 99 transactions |
| Buy: 225 001 | Sell: 293 391 |
Forecast:
16:00 - $329.26
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $329.26
Forecast 2: 16:00 - $329.26
Forecast 3: 16:00 - $329.26
SCORE
-10.00
Sell
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $328.99 (0.04% ) |
| Volume | 0.596 mill |
| Avg. Vol. | 1.071 mill |
| % of Avg. Vol | 55.68 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SWAV
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $235.06 | N/A | Active |
|---|
SWAV
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-09 22:47:00 - Press Release
Shareholder Investigation: Halper Sadeh Llc Investigates Swav, Airc, Inrd
New york , april 9, 2024 /prnewswire/ -- halper sadeh llc, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: shockwave medical, inc. (nasdaq: swav)'s sale to johnson & johnson for $335.00 per share in cash. if you are a shockwave shareholder, click here to learn more about your rights and options.
2024-04-09 20:05:00 - Press Release
Investigation: The M&a Class Action Firm Announces An Investigation Of Shockwave Medical, Inc. - Swav
New york , april 9, 2024 /prnewswire/ -- monteverde & associates pc (the "m&a class action firm"), has recovered money for shareholders and is recognized as a top 50 firm in the 2018-2022 iss securities class action services report. we are headquartered at the empire state building in new york city and is investigating shockwave medical, inc. (nasdaq: swav), relating to its proposed sale to johnson & johnson.
2024-04-08 20:49:00 - Press Release
Shockwave Medical Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Shockwave Medical, Inc. - Swav
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of shockwave medical, inc. (nasdaqgs: swav) to johnson & johnson (nyse: jnj). under the terms of the proposed transaction, shareholders of shockwave will receive $335.00 in cash for each share of shockwave that they own. ksf is seeking to determine whether this consideration and the process that led to it are.
2024-04-08 16:03:00 - Press Release
Shockwave Reducer Demonstrates Consistent, Positive Results In ‘real-world' Study
Six-month results from reducer-i trial add to positive evidence of the coronary sinus reducer to treat refractory angina six-month results from reducer-i trial add to positive evidence of the coronary sinus reducer to treat refractory angina
2024-04-05 14:55:00 - Press Release
Alert: Rowley Law Pllc Is Investigating Proposed Acquisition Of Shockwave Medical, Inc.
New york, april 5, 2024 /prnewswire/ -- rowley law pllc is investigating potential securities law violations by shockwave medical, inc. (nasdaq: swav) and its board of directors concerning the proposed acquisition of the company by johnson & johnson (nyse: jnj). stockholders will receive $335.00 for each share of shockwave medical stock that they hold.
Latest News
2024-04-25 19:21:29 - Zacks Investment Research
Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
In the latest trading session, Shockwave Medical (SWAV) closed at $328.99, marking a +0.04% move from the previous day.
2024-04-22 09:56:07 - Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
2024-04-19 19:20:16 - Zacks Investment Research
Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
Shockwave Medical (SWAV) concluded the recent trading session at $329, signifying a +0.45% move from its prior day's close.
2024-04-16 13:05:05 - Schwab Network
Johnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways
CFRA views the newly announced $13.1B Johnson & Johnson (JNJ) shockwave deal as positive. David Toung and Sel Hardy discuss the takeaways from Johnson & Johnson's earnings.
2024-04-15 13:15:35 - Zacks Investment Research
Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
Shockwave Medical (SWAV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2024-04-10 08:56:04 - Zacks Investment Research
Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
We have narrowed our search to five high-flying Nasdaq Composite listed non-tech stocks with more upside left. These are: CELH, SWAV, COIN, HOOD, IBKR.
2024-04-09 12:01:06 - Zacks Investment Research
Shockwave Medical's (SWAV) Reducer Receives Positive Results
Shockwave Medical (SWAV) announces the 'real-world' results of the REDUCER-I study, which is intended to collect long-term outcomes on Shockwave Reducer, a novel treatment for refractory angina.
2024-04-08 11:55:08 - MarketBeat
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
On April 5, 2024, Johnson & Johnson NYSE: JNJ announced its intent to acquire Shockwave Medical Inc. NASDAQ: SWAV for $13.1 billion. Under the terms of the proposed deal, JNJ will pay $335 per share, which is a 4.75% premium compared to Shockwave's closing price on April 4, 2024.
2024-04-05 16:31:04 - Zacks Investment Research
Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?
News of healthcare behemoth Johnson & Johnson (JNJ) acquiring medical device company ShockWave Medical (SWAV) for $13.1 billion made headlines this morning.
2024-04-05 12:25:55 - Investopedia
J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio
Johnson & Johnson (JNJ) announced Friday it was buying Shockwave Medical (SWAV) for $13.1 billion in cash, pushing shares of the maker of cardiovascular catheters to near all-time highs.